Javier
López Pais
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Investigaciones Cardiovasculares Carlos III (2)
2022
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
2021
-
Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)
Basic Research in Cardiology, Vol. 116, Núm. 1